home / stock / mdxg / mdxg news


MDXG News and Press, MiMedx Group Inc From 07/18/23

Stock Information

Company Name: MiMedx Group Inc
Stock Symbol: MDXG
Market: OTC
Website: mimedx.com

Menu

MDXG MDXG Quote MDXG Short MDXG News MDXG Articles MDXG Message Board
Get MDXG Alerts

News, Short Squeeze, Breakout and More Instantly...

MDXG - MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1

MARIETTA, Ga., July 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2023 after the market close on Tuesday, August 1...

MDXG - MiMedx names Doug Rice as new CFO

2023-07-05 13:52:06 ET MiMedx ( NASDAQ: MDXG ) said Wednesday that it has appointed Doug Rice as the company's new chief financial officer. Rice will replace Pete Carlson, who has served in the CFO role since March 2020. Press Release . ...

MDXG - MIMEDX Appoints Doug Rice as Chief Financial Officer

MARIETTA, Ga., July 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has appointed Doug Rice as the Company’s Chief Financial Officer, effective today. Pete Carlson, who has served in that role si...

MDXG - MiMedx Group climbs 4%, reports CEO buying $640K stock

2023-06-27 03:18:02 ET MiMedx Group ( NASDAQ: MDXG ) stock price up 4.1% to $6.35 on Monday during late hours, the company filed Form 4 that shows CEO, Joseph H. Capper buying at total of 100k shares for $640K. On June 22 and June 23, 2023, he bought 57,975 and&#x...

MDXG - MiMedx pulls plug on knee osteoarthritis, regenerative medicine programs

2023-06-20 16:54:49 ET MiMedx Group ( NASDAQ: MDXG ) said that it was pulling the plug on its knee osteoarthritis and regenerative medicine programs in order to focus on accelerating growth for its wound and surgical business. The wound care products company, which specializes i...

MDXG - MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

Suspending Current Activities Associated with Knee Osteoarthritis Program and Disbanding Regenerative Medicine Business Unit Restructuring Expected to Generate Approximately $25 Million in Annualized Savings Raising Expectations to Deliver Mid-Teens Percentage Net Sales Growth D...

MDXG - PACW, MDXG and ARQQ are among pre market gainers

2023-05-23 08:29:22 ET CohBar ( CWBR ) +100% Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy. HeartCore Enterprises ( HTCR ) +59% Q1 earnings call rel...

MDXG - MiMedx's Post-Q1 2023 Surge Could Result In Profit-Taking

2023-05-06 05:25:23 ET Summary Following the release of Q1 2023 results, MiMedx Group, Inc. shares are soaring on double-digit revenue growth and bottom line on track to turn a profit. MiMedx Group, Inc. is a Marietta, Georgia-based developer and distributor of placental tissue al...

MDXG - MiMedx surges ~30% after Q1 revenue growth, cost controls drive down net loss

2023-05-03 12:21:19 ET MiMedx ( NASDAQ: MDXG ) stock ~28% on Wednesday after Q1 results beat estimates. Net sales grew +21.7% Y/Y to $71.68M. Meanwhile, net loss narrowed to -$4.98M, compared to -$10.49M in Q1 2022. The company said revenue growth and cost controls helpe...

MDXG - MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript

2023-05-02 23:08:05 ET MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Conference Call May 02, 2023 05:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group ...

Previous 10 Next 10